Global Microneedle Drug Delivery Systems Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR072510731

Publication Date:

July 22, 2025

Pages:

115

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Microneedle Drug Delivery Systems market size was valued at US$ 12.3 million in 2024 and is forecast to a readjusted size of USD 557 million by 2031 with a CAGR of 73.2% during review period.
Microneedle drug delivery systems usually include Hollow Microneedle Technology microneedle and Dissolving Microneedles Technology microneedle technology, offer patient-friendly delivery solutions for vaccines or difficult-to-deliver biologics for particularly needle-phobic patients.
In this report, we mainly study the forecast market due to there is no product on the market, most product on the research.
Microneedles are a rapidly growing technology developed to solve issues surrounding intradermal drug administration. While many microneedle platforms have been developed over nearly 2 decades, the issues and concerns remain largely the same.
The classification of Microneedle Drug Delivery Systems includes Hollow Microneedle Technology, Solid Microneedle Technology and Dissolving Microneedles Technology, and the proportion of Hollow Microneedle Technology occupies the most proportions.
Microneedle Drug Delivery Systems is widely used in Drug Delivery, Vaccine Delivery and other field. The most proportion of Microneedle Drug Delivery Systems is used for vaccine delivery.
3M, Zosano Pharma, Becton-Dickinson(BD)Technologies, Nanopass Technologies, Corium, Valeritas are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report is a detailed and comprehensive analysis for global Microneedle Drug Delivery Systems market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Microneedle Drug Delivery Systems market size and forecasts, in consumption value ($ Million), 2020-2031
Global Microneedle Drug Delivery Systems market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Microneedle Drug Delivery Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Microneedle Drug Delivery Systems market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Microneedle Drug Delivery Systems
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Microneedle Drug Delivery Systems market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include KINDEVA, Zosano Pharma, Becton-Dickinson(BD)Technologies, Nanopass Technologies, Corium, Valeritas, Nitto, Microdermics, TheraJect, Inc, Vaxxas, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Microneedle Drug Delivery Systems market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Hollow Microneedle Technology
Solid Microneedle Technology
Dissolving Microneedles Technology
Market segment by Application
Drug Delivery
Vaccine Delivery
Market segment by players, this report covers
KINDEVA
Zosano Pharma
Becton-Dickinson(BD)Technologies
Nanopass Technologies
Corium
Valeritas
Nitto
Microdermics
TheraJect, Inc
Vaxxas
Lohmann Therapie-Systeme AG
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Microneedle Drug Delivery Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Microneedle Drug Delivery Systems, with revenue, gross margin, and global market share of Microneedle Drug Delivery Systems from 2020 to 2025.
Chapter 3, the Microneedle Drug Delivery Systems competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Microneedle Drug Delivery Systems market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Microneedle Drug Delivery Systems.
Chapter 13, to describe Microneedle Drug Delivery Systems research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Microneedle Drug Delivery Systems by Type
1.3.1 Overview: Global Microneedle Drug Delivery Systems Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Microneedle Drug Delivery Systems Consumption Value Market Share by Type in 2024
1.3.3 Hollow Microneedle Technology
1.3.4 Solid Microneedle Technology
1.3.5 Dissolving Microneedles Technology
1.4 Global Microneedle Drug Delivery Systems Market by Application
1.4.1 Overview: Global Microneedle Drug Delivery Systems Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Drug Delivery
1.4.3 Vaccine Delivery
1.5 Global Microneedle Drug Delivery Systems Market Size & Forecast
1.6 Global Microneedle Drug Delivery Systems Market Size and Forecast by Region
1.6.1 Global Microneedle Drug Delivery Systems Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Microneedle Drug Delivery Systems Market Size by Region, (2020-2031)
1.6.3 North America Microneedle Drug Delivery Systems Market Size and Prospect (2020-2031)
1.6.4 Europe Microneedle Drug Delivery Systems Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Microneedle Drug Delivery Systems Market Size and Prospect (2020-2031)
1.6.6 South America Microneedle Drug Delivery Systems Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Microneedle Drug Delivery Systems Market Size and Prospect (2020-2031)
2 Company Profiles
2.1 KINDEVA
2.1.1 KINDEVA Details
2.1.2 KINDEVA Major Business
2.1.3 KINDEVA Microneedle Drug Delivery Systems Product and Solutions
2.1.4 KINDEVA Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 KINDEVA Recent Developments and Future Plans
2.2 Zosano Pharma
2.2.1 Zosano Pharma Details
2.2.2 Zosano Pharma Major Business
2.2.3 Zosano Pharma Microneedle Drug Delivery Systems Product and Solutions
2.2.4 Zosano Pharma Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Zosano Pharma Recent Developments and Future Plans
2.3 Becton-Dickinson(BD)Technologies
2.3.1 Becton-Dickinson(BD)Technologies Details
2.3.2 Becton-Dickinson(BD)Technologies Major Business
2.3.3 Becton-Dickinson(BD)Technologies Microneedle Drug Delivery Systems Product and Solutions
2.3.4 Becton-Dickinson(BD)Technologies Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Becton-Dickinson(BD)Technologies Recent Developments and Future Plans
2.4 Nanopass Technologies
2.4.1 Nanopass Technologies Details
2.4.2 Nanopass Technologies Major Business
2.4.3 Nanopass Technologies Microneedle Drug Delivery Systems Product and Solutions
2.4.4 Nanopass Technologies Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Nanopass Technologies Recent Developments and Future Plans
2.5 Corium
2.5.1 Corium Details
2.5.2 Corium Major Business
2.5.3 Corium Microneedle Drug Delivery Systems Product and Solutions
2.5.4 Corium Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Corium Recent Developments and Future Plans
2.6 Valeritas
2.6.1 Valeritas Details
2.6.2 Valeritas Major Business
2.6.3 Valeritas Microneedle Drug Delivery Systems Product and Solutions
2.6.4 Valeritas Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Valeritas Recent Developments and Future Plans
2.7 Nitto
2.7.1 Nitto Details
2.7.2 Nitto Major Business
2.7.3 Nitto Microneedle Drug Delivery Systems Product and Solutions
2.7.4 Nitto Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Nitto Recent Developments and Future Plans
2.8 Microdermics
2.8.1 Microdermics Details
2.8.2 Microdermics Major Business
2.8.3 Microdermics Microneedle Drug Delivery Systems Product and Solutions
2.8.4 Microdermics Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Microdermics Recent Developments and Future Plans
2.9 TheraJect, Inc
2.9.1 TheraJect, Inc Details
2.9.2 TheraJect, Inc Major Business
2.9.3 TheraJect, Inc Microneedle Drug Delivery Systems Product and Solutions
2.9.4 TheraJect, Inc Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 TheraJect, Inc Recent Developments and Future Plans
2.10 Vaxxas
2.10.1 Vaxxas Details
2.10.2 Vaxxas Major Business
2.10.3 Vaxxas Microneedle Drug Delivery Systems Product and Solutions
2.10.4 Vaxxas Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Vaxxas Recent Developments and Future Plans
2.11 Lohmann Therapie-Systeme AG
2.11.1 Lohmann Therapie-Systeme AG Details
2.11.2 Lohmann Therapie-Systeme AG Major Business
2.11.3 Lohmann Therapie-Systeme AG Microneedle Drug Delivery Systems Product and Solutions
2.11.4 Lohmann Therapie-Systeme AG Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Lohmann Therapie-Systeme AG Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Microneedle Drug Delivery Systems Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Microneedle Drug Delivery Systems by Company Revenue
3.2.2 Top 3 Microneedle Drug Delivery Systems Players Market Share in 2024
3.2.3 Top 6 Microneedle Drug Delivery Systems Players Market Share in 2024
3.3 Microneedle Drug Delivery Systems Market: Overall Company Footprint Analysis
3.3.1 Microneedle Drug Delivery Systems Market: Region Footprint
3.3.2 Microneedle Drug Delivery Systems Market: Company Product Type Footprint
3.3.3 Microneedle Drug Delivery Systems Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Microneedle Drug Delivery Systems Consumption Value and Market Share by Type (2020-2025)
4.2 Global Microneedle Drug Delivery Systems Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
5.1 Global Microneedle Drug Delivery Systems Consumption Value Market Share by Application (2020-2025)
5.2 Global Microneedle Drug Delivery Systems Market Forecast by Application (2026-2031)
6 North America
6.1 North America Microneedle Drug Delivery Systems Consumption Value by Type (2020-2031)
6.2 North America Microneedle Drug Delivery Systems Market Size by Application (2020-2031)
6.3 North America Microneedle Drug Delivery Systems Market Size by Country
6.3.1 North America Microneedle Drug Delivery Systems Consumption Value by Country (2020-2031)
6.3.2 United States Microneedle Drug Delivery Systems Market Size and Forecast (2020-2031)
6.3.3 Canada Microneedle Drug Delivery Systems Market Size and Forecast (2020-2031)
6.3.4 Mexico Microneedle Drug Delivery Systems Market Size and Forecast (2020-2031)
7 Europe
7.1 Europe Microneedle Drug Delivery Systems Consumption Value by Type (2020-2031)
7.2 Europe Microneedle Drug Delivery Systems Consumption Value by Application (2020-2031)
7.3 Europe Microneedle Drug Delivery Systems Market Size by Country
7.3.1 Europe Microneedle Drug Delivery Systems Consumption Value by Country (2020-2031)
7.3.2 Germany Microneedle Drug Delivery Systems Market Size and Forecast (2020-2031)
7.3.3 France Microneedle Drug Delivery Systems Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Microneedle Drug Delivery Systems Market Size and Forecast (2020-2031)
7.3.5 Russia Microneedle Drug Delivery Systems Market Size and Forecast (2020-2031)
7.3.6 Italy Microneedle Drug Delivery Systems Market Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Microneedle Drug Delivery Systems Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Microneedle Drug Delivery Systems Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Microneedle Drug Delivery Systems Market Size by Region
8.3.1 Asia-Pacific Microneedle Drug Delivery Systems Consumption Value by Region (2020-2031)
8.3.2 China Microneedle Drug Delivery Systems Market Size and Forecast (2020-2031)
8.3.3 Japan Microneedle Drug Delivery Systems Market Size and Forecast (2020-2031)
8.3.4 South Korea Microneedle Drug Delivery Systems Market Size and Forecast (2020-2031)
8.3.5 India Microneedle Drug Delivery Systems Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Microneedle Drug Delivery Systems Market Size and Forecast (2020-2031)
8.3.7 Australia Microneedle Drug Delivery Systems Market Size and Forecast (2020-2031)
9 South America
9.1 South America Microneedle Drug Delivery Systems Consumption Value by Type (2020-2031)
9.2 South America Microneedle Drug Delivery Systems Consumption Value by Application (2020-2031)
9.3 South America Microneedle Drug Delivery Systems Market Size by Country
9.3.1 South America Microneedle Drug Delivery Systems Consumption Value by Country (2020-2031)
9.3.2 Brazil Microneedle Drug Delivery Systems Market Size and Forecast (2020-2031)
9.3.3 Argentina Microneedle Drug Delivery Systems Market Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Microneedle Drug Delivery Systems Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Microneedle Drug Delivery Systems Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Microneedle Drug Delivery Systems Market Size by Country
10.3.1 Middle East & Africa Microneedle Drug Delivery Systems Consumption Value by Country (2020-2031)
10.3.2 Turkey Microneedle Drug Delivery Systems Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Microneedle Drug Delivery Systems Market Size and Forecast (2020-2031)
10.3.4 UAE Microneedle Drug Delivery Systems Market Size and Forecast (2020-2031)
11 Market Dynamics
11.1 Microneedle Drug Delivery Systems Market Drivers
11.2 Microneedle Drug Delivery Systems Market Restraints
11.3 Microneedle Drug Delivery Systems Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Microneedle Drug Delivery Systems Industry Chain
12.2 Microneedle Drug Delivery Systems Upstream Analysis
12.3 Microneedle Drug Delivery Systems Midstream Analysis
12.4 Microneedle Drug Delivery Systems Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

KINDEVA
Zosano Pharma
Becton-Dickinson(BD)Technologies
Nanopass Technologies
Corium
Valeritas
Nitto
Microdermics
TheraJect, Inc
Vaxxas
Lohmann Therapie-Systeme AG

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂